6-bromo-3-(methoxymethoxymethylidene)-1H-indol-2-one | 303743-53-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 6-bromo-3-(methoxymethoxymethylidene)-1H-indol-2-one
• CAS: 303743-53-5
• 化学式: C₁₁H₁₀BrNO₃
• 分子量: 284.109
• InChiKey: DEMLOPIXQGDPER-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  47.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  6-bromo-3-(methoxymethoxymethylidene)-1H-indol-2-one 在 potassium permanganate 、 sodium periodate 、 potassium carbonate 作用下， 以 1,4-二氧六环 、 叔丁醇 为溶剂， 以88%的产率得到6-溴靛红
  参考文献：
  名称：

  Structure-based design and parallel synthesis of N-benzyl isatin oximes as JNK3 MAP kinase inhibitors

  摘要：

  A series of N-benzylated isatin oximes were developed as inhibitors of the mitogen-activated kinase, JNK3. X-ray crystallographic structures aided in the design and synthesis of novel, selective compounds, that inhibit JNK3, but not p38 MAP kinase and provided key insights into understanding the behavior of gatekeeper residue methionine-146 in determining target selectivity for this series.

  DOI：

  10.1016/j.bmcl.2009.03.043
• 作为产物：
  描述：

  6-bromo-3-(hydroxymethylidene)-1H-indol-2-one 、 氯甲基甲基醚 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以80%的产率得到6-bromo-3-(methoxymethoxymethylidene)-1H-indol-2-one
  参考文献：
  名称：

  Structure-based design and parallel synthesis of N-benzyl isatin oximes as JNK3 MAP kinase inhibitors

  摘要：

  A series of N-benzylated isatin oximes were developed as inhibitors of the mitogen-activated kinase, JNK3. X-ray crystallographic structures aided in the design and synthesis of novel, selective compounds, that inhibit JNK3, but not p38 MAP kinase and provided key insights into understanding the behavior of gatekeeper residue methionine-146 in determining target selectivity for this series.

  DOI：

  10.1016/j.bmcl.2009.03.043

文献信息

• Structure-based design and parallel synthesis of N-benzyl isatin oximes as JNK3 MAP kinase inhibitors
  作者：Jingrong Cao、Huai Gao、Guy Bemis、Francesco Salituro、Mark Ledeboer、Edmund Harrington、Susanne Wilke、Paul Taslimi、S. Pazhanisamy、Xiaoling Xie、Marc Jacobs、Jeremy Green

  DOI：10.1016/j.bmcl.2009.03.043

  日期：2009.5

  A series of N-benzylated isatin oximes were developed as inhibitors of the mitogen-activated kinase, JNK3. X-ray crystallographic structures aided in the design and synthesis of novel, selective compounds, that inhibit JNK3, but not p38 MAP kinase and provided key insights into understanding the behavior of gatekeeper residue methionine-146 in determining target selectivity for this series.